Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-11

Clinical Trial Update: Evaluation of Pigmented Skin Lesions With MelaFind(R) System [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the MelaFind diagnostic system for pigmented skin lesions in melanoma completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MelaFind

Snippet

Sponsor: MELA Sciences, Inc. | Conditions: Melanoma | Phase 3 | Status: COMPLETED | Results posted: 2009-11-11